Pfizer wins favorable Canadian ruling on Lipitor patent

03/23/2008 | American City Business Journals

Pfizer announced that the Federal Court of Appeal of Canada has upheld a patent that prevents generic-drug maker Ranbaxy Laboratories Ltd. from marketing a copy of Lipitor before the patent lapses in July 2010. A Pfizer representative said the ruling helps motivate drugmakers "to make the significant high-risk investments necessary to develop new life-saving medicines." Ranbaxy may ask the Supreme Court of Canada to review the decision.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC